Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques.

Beq S, Rozlan S, Gautier D, Parker R, Mersseman V, Schilte C, Assouline B, Rancé I, Lavedan P, Morre M, Cheynier R.

Blood. 2009 Jul 23;114(4):816-25. doi: 10.1182/blood-2008-11-191288. Epub 2009 Apr 7.

2.

IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy.

Beq S, Nugeyre MT, Ho Tsong Fang R, Gautier D, Legrand R, Schmitt N, Estaquier J, Barré-Sinoussi F, Hurtrel B, Cheynier R, Israël N.

J Immunol. 2006 Jan 15;176(2):914-22.

3.

Rapid modifications of peripheral T-cell subsets that express CD127 in macaques treated with recombinant IL-7.

Dereuddre-Bosquet N, Vaslin B, Delache B, Brochard P, Clayette P, Aubenque C, Morre M, Assouline B, Le Grand R.

J Med Primatol. 2007 Aug;36(4-5):228-37.

PMID:
17669211
4.

T lymphocyte migration to lymph nodes is maintained during homeostatic proliferation.

Kodera M, Grailer JJ, Karalewitz AP, Subramanian H, Steeber DA.

Microsc Microanal. 2008 Jun;14(3):211-24. doi: 10.1017/S1431927608080215. Epub 2008 Mar 3.

PMID:
18312727
5.

Chemokine networks and in vivo T-lymphocyte trafficking in nonhuman primates.

Clay CC, Rodrigues DS, Brignolo LL, Spinner A, Tarara RP, Plopper CG, Leutenegger CM, Esser U.

J Immunol Methods. 2004 Oct;293(1-2):23-42.

PMID:
15541274
6.

Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infection.

Fluur C, De Milito A, Fry TJ, Vivar N, Eidsmo L, Atlas A, Federici C, Matarrese P, Logozzi M, Rajnavölgyi E, Mackall CL, Fais S, Chiodi F, Rethi B.

J Immunol. 2007 Apr 15;178(8):5340-50.

7.

Priming of T cells to Fas-mediated proliferative signals by interleukin-7.

Rethi B, Vivar N, Sammicheli S, Fluur C, Ruffin N, Atlas A, Rajnavolgyi E, Chiodi F.

Blood. 2008 Aug 15;112(4):1195-204. doi: 10.1182/blood-2007-12-126698. Epub 2008 Apr 25.

8.

The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells.

Crome SQ, Wang AY, Kang CY, Levings MK.

Eur J Immunol. 2009 Jun;39(6):1480-93. doi: 10.1002/eji.200838908.

9.

The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance.

Di Carlo E, D'Antuono T, Pompa P, Giuliani R, Rosini S, Stuppia L, Musiani P, Sorrentino C.

Clin Cancer Res. 2009 May 1;15(9):2979-87. doi: 10.1158/1078-0432.CCR-08-1951. Epub 2009 Apr 14.

10.

TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag.

Cottalorda A, Mercier BC, Mbitikon-Kobo FM, Arpin C, Teoh DY, McMichael A, Marvel J, Bonnefoy-Bérard N.

Eur J Immunol. 2009 Oct;39(10):2673-81. doi: 10.1002/eji.200939627.

11.

IL-7 is essential for lymphopenia-driven turnover of colitogenic CD4(+) memory T cells in chronic colitis.

Tomita T, Kanai T, Totsuka T, Nemoto Y, Okamoto R, Tsuchiya K, Sakamoto N, Ohteki T, Hibi T, Watanabe M.

Eur J Immunol. 2009 Oct;39(10):2737-47. doi: 10.1002/eji.200838905.

12.

CD25 blockade protects T cells from activation-induced cell death (AICD) via maintenance of TOSO expression.

Richter GH, Mollweide A, Hanewinkel K, Zobywalski C, Burdach S.

Scand J Immunol. 2009 Sep;70(3):206-15. doi: 10.1111/j.1365-3083.2009.02281.x.

13.

Interleukin-8-induced human peripheral blood B-lymphocyte chemotaxis in vitro.

Schratzberger P, Dunzendorfer S, Reinisch N, Kähler CM, Wiedermann CJ.

Immunol Lett. 1997 Aug;58(3):167-70.

PMID:
9293398
14.

Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans.

Fenoglio D, Poggi A, Catellani S, Battaglia F, Ferrera A, Setti M, Murdaca G, Zocchi MR.

Blood. 2009 Jun 25;113(26):6611-8. doi: 10.1182/blood-2009-01-198028. Epub 2009 Apr 24.

15.

Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.

Nagamine I, Yamaguchi Y, Ohara M, Ikeda T, Okada M.

Hiroshima J Med Sci. 2009 Mar;58(1):37-44.

PMID:
19400555
16.

IL-7 adjuvant treatment enhances long-term tumor-antigen-specific CD8+ T-cell responses after immunization with recombinant lentivector.

Colombetti S, Lévy F, Chapatte L.

Blood. 2009 Jun 25;113(26):6629-37. doi: 10.1182/blood-2008-05-155309. Epub 2009 Apr 21.

17.

IL-7 drives T cell-mediated bone loss following ovariectomy.

Robbie-Ryan M, Pacifici R, Weitzmann MN.

Ann N Y Acad Sci. 2006 Apr;1068:348-51.

PMID:
16831936
18.

Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.

Yarkoni S, Sagiv Y, Kaminitz A, Farkas DL, Askenasy N.

Eur J Immunol. 2009 Oct;39(10):2850-64. doi: 10.1002/eji.200839190.

19.

[CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].

Theze J.

Bull Acad Natl Med. 2008 Oct;192(7):1453-66; discussion 1466-8. Review. French.

PMID:
19445368
20.

Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6.

Najar M, Rouas R, Raicevic G, Boufker HI, Lewalle P, Meuleman N, Bron D, Toungouz M, Martiat P, Lagneaux L.

Cytotherapy. 2009;11(5):570-83. doi: 10.1080/14653240903079377.

PMID:
19565371

Supplemental Content

Support Center